Potentially lethal drugs

Some anaesthetists are threatening to quit the country if their lesser-trained assistants are allowed to administer potentially lethal drugs.

Australia and the United States allow the practice, which is recommended in a report as a way to ease a critical shortage of anaesthetists in smaller hospitals.

But anaesthetists train for up to 13 years and say the profession should remain a "medical specialty", with 45% saying they would consider leaving New Zealand, and that patients could be at risk.

The Anaesthesia 2020 report by the Anaesthesia Resource Review Group found the workforce in public hospitals was "severely stressed in some regions".

"It's likely to come under more stress as demand for anaesthetic resources increases, with a risk of service failure unless measures are taken."

The report called it a 100/40 problem – an anticipated 100% increase in demand in a decade but a projected funding increase of only 40%.

The lure of Australian salaries was also a problem.

Opposition centred on the assistants – nurses or doctors – having less medical or anaesthetic training, that patients were at a greater risk of harm, that it was cost-saving rather than an improvement in services, and that assistants were unsuitable for remote areas anyway because of a lack of supervision.

Australian and New Zealand College of Anaesthetists spokesman Dr Geoff Long said there was a concentration of skills in urban areas, and particular shortages in Greymouth, the West Coast and Invercargill.

He said smaller centres were forced to use expensive locums or, as in a third of all departments, restrict annual leave.

There are about 530 specialists and a further 155 are being trained.

Suhagra 100 consists of Sildenafil Citrate

   
  Suhagra 100 consists of Sildenafil Citrate, an active ingredient which is also found in its brand equivalent Viagra. Sildenafil was developed in 1991 for treating chest pain. Later, during clinical trials it was found that Sildenafil citrate had the capacity to induce strong erections in impotent men(ed). Subsequently, it was approved by the FDA as an erection encouraging pill.
   
   

A routine cancer screen can identify certain cancers.

Screen for the Big Three
A routine cancer screen can identify certain cancers before symptoms occur, when your chances of beating the disease are greatest. The "big three" to screen for regularly include breast, cervical, and colorectal cancers. The CDC recommends that women get regular clinical and self breast exams by age 20 and mammograms to test for breast cancer every one to two years after the age of 40. In addition, women should have a regular Pap smear starting at age 21 or within three years of first having sex to check for cervical cancer. For both men and women, the CDC recommends a colorectal cancer screening soon after turning 50, then routinely after that. Catching these types of cancer early can make treatment more effective, giving you a better chance at that long, healthy life.